212 related articles for article (PubMed ID: 17205822)
21. Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis.
Migliori M; Giovannini L; Panichi V; Filippi C; Taccola D; Origlia N; Mannari C; Camussi G
Int J Immunopathol Pharmacol; 2005; 18(4):779-90. PubMed ID: 16388728
[TBL] [Abstract][Full Text] [Related]
22. Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis.
Cantaluppi V; Medica D; Mannari C; Stiaccini G; Figliolini F; Dellepiane S; Quercia AD; Migliori M; Panichi V; Giovannini L; Bruno S; Tetta C; Biancone L; Camussi G
Nephrol Dial Transplant; 2015 Mar; 30(3):410-22. PubMed ID: 25488895
[TBL] [Abstract][Full Text] [Related]
23. Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis.
Câmpean V; Karpe B; Haas C; Atalla A; Peters H; Rupprecht H; Liebner S; Acker T; Plate K; Amann K
Am J Physiol Renal Physiol; 2008 May; 294(5):F1174-84. PubMed ID: 18272601
[TBL] [Abstract][Full Text] [Related]
24. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy.
Nakatsue T; Koike H; Han GD; Suzuki K; Miyauchi N; Yuan H; Salant DJ; Gejyo F; Shimizu F; Kawachi H
Kidney Int; 2005 Jun; 67(6):2239-53. PubMed ID: 15882266
[TBL] [Abstract][Full Text] [Related]
25. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
[TBL] [Abstract][Full Text] [Related]
26. Temporal and spatial expression of podocyte-associated molecules are accompanied by proteinuria in IgA nephropathy rat model.
Lu H; Chen LL; Jiang XY; Mo Y; Ling YH; Sun LZ
Physiol Res; 2013; 62(1):35-45. PubMed ID: 23173680
[TBL] [Abstract][Full Text] [Related]
27. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
[TBL] [Abstract][Full Text] [Related]
28. Tripterygium glycoside fraction n2 ameliorates adriamycin-induced nephrotic syndrome in rats by suppressing apoptosis.
Wang XW; Tian RM; Yang YQ; Wang K; Li EN; Han XD; Bao K; Mao W; Xu HT; Liu B; Xu P
J Ethnopharmacol; 2020 Jul; 257():112789. PubMed ID: 32234597
[TBL] [Abstract][Full Text] [Related]
29. The novel NF-kappaB activation inhibitor dehydroxymethyl-epoxyquinomicin suppresses anti-Thy1.1-induced glomerulonephritis in rats.
Kosaka T; Miyajima A; Kikuchi E; Horiguchi Y; Umezawa K; Ohigashi T; Nakashima J; Asano T; Oya M
Nephron Exp Nephrol; 2008; 110(1):e17-24. PubMed ID: 18685260
[TBL] [Abstract][Full Text] [Related]
30. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
31. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic mechanism of Saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomerulonephritis.
Li P; Gong Y; Zu N; Li Y; Wang B; Shimizu F
Nephron Exp Nephrol; 2005; 101(4):e111-8. PubMed ID: 16103731
[TBL] [Abstract][Full Text] [Related]
33. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression.
Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T
Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745
[TBL] [Abstract][Full Text] [Related]
34. CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes.
Tossidou I; Teng B; Drobot L; Meyer-Schwesinger C; Worthmann K; Haller H; Schiffer M
J Biol Chem; 2010 Aug; 285(33):25285-95. PubMed ID: 20457601
[TBL] [Abstract][Full Text] [Related]
35. Diversities of podocyte molecular changes induced by different antiproteinuria drugs.
Xing Y; Ding J; Fan Q; Guan N
Exp Biol Med (Maywood); 2006 May; 231(5):585-93. PubMed ID: 16636307
[TBL] [Abstract][Full Text] [Related]
36. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
37. FK506 ameliorates proteinuria and glomerular lesions induced by anti-Thy 1.1 monoclonal antibody 1-22-3.
Ikezumi Y; Kanno K; Koike H; Tomita M; Uchiyama M; Shimizu F; Kawachi H
Kidney Int; 2002 Apr; 61(4):1339-50. PubMed ID: 11918741
[TBL] [Abstract][Full Text] [Related]
38. Honokiol, a small molecular weight natural product, alleviates experimental mesangial proliferative glomerulonephritis.
Chiang CK; Sheu ML; Hung KY; Wu KD; Liu SH
Kidney Int; 2006 Aug; 70(4):682-9. PubMed ID: 16807544
[TBL] [Abstract][Full Text] [Related]
39. Key molecular events in puromycin aminonucleoside nephrosis rats.
Guan N; Ding J; Deng J; Zhang J; Yang J
Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of cyclooxygenase-1 and the PGE2 receptor EP2 in rat and human mesangioproliferative glomerulonephritis.
Hartner A; Pahl A; Brune K; Goppelt-Struebe M
Inflamm Res; 2000 Jul; 49(7):345-54. PubMed ID: 10959556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
